The role of anticonvulsants in treatment-resistant anxiety disorders

被引：0
|
作者：
Tukel, Rasit [1 ]
机构：
[1] IU Istanbul, Tip Fak, Psikiyatri Anabilim Dali, Istanbul, Turkey
来源：
KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY | 2009年 / 19卷
关键词：
Anticonvulsants; panic disorder; generalized anxiety disorder; social anxiety disorder; obsessive-compulsive disorder; posttraumatic stress disorder; PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND; PREGABALIN; MULTICENTER; EFFICACY; GABAPENTIN;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Antidepressants are the first-line pharmacological treatment approach for the anxiety disorders. Other pharmacotherapy options for anxiety disorders include benzodiazepines, atypical antipsychotics, and anticonvulsants. Evidence provided by double-blind, placebo-controlled trials demonstrates the effectiveness of pregabalin and valproic acid for generalized anxiety disorder, pregabalin and gabapentin for social anxiety disorder, valproic acid for panic disorder, and lamotrigine for posttraumatic stress disorder. Further research is needed to determine the efficacy of anticonvulsants for the treatment-resistant anxiety disorder patients.
引用
收藏
页码：S84 / S86
页数：3
相关论文
共 50 条
  • [41] The multiple diagnoses of comorbid anxiety disorders and higher interpersonal sensitivity predict treatment-resistant depression
    Mogi, Taichi
    Yoshino, Aihide
    [J]. ASIAN JOURNAL OF PSYCHIATRY, 2017, 26 : 131 - 135
  • [42] Novel Psilocin Prodrugs with Altered Pharmacological Properties as Candidate Therapies for Treatment-Resistant Anxiety Disorders
    Raithatha, Sheetal A.
    Hagel, Jillian M.
    Matinkhoo, Kaveh
    Yu, Lisa
    Press, David
    Cook, Sarah G.
    Sharma, Govinda
    Dhananjaya, D.
    Jensen, Glynnis
    Lee, Jessica B.
    Cai, Charlie
    Gallant, Jonathan
    Bains, Jaideep
    Tucker, Joseph E.
    Facchini, Peter J.
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2023, 67 (02) : 1024 - 1043
  • [43] Treatment-resistant schizophrenia - The role of clozapine
    Meltzer, HY
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 1997, 14 (01) : 1 - 20
  • [44] Role of Psychedelics in Treatment-Resistant Depression
    Kamal, Shubham
    Jha, Manish Kumar
    Radhakrishnan, Rajiv
    [J]. PSYCHIATRIC CLINICS OF NORTH AMERICA, 2023, 46 (02) : 291 - 305
  • [45] Role of aripiprazole in treatment-resistant schizophrenia
    Mossaheb, Nilufar
    Kaufmann, Rainer M.
    [J]. NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2012, 8 : 235 - 244
  • [46] The Role of Clozapine in Treatment-Resistant Schizophrenia
    Kane, John M.
    Correll, Christoph U.
    [J]. JAMA PSYCHIATRY, 2016, 73 (03) : 187 - 188
  • [47] Clozapine in treatment-resistant mania, bipolar manic-depressive disorders, and treatment-resistant depression.
    Vestergaard, P
    [J]. NORDIC JOURNAL OF PSYCHIATRY, 1997, 51 : 53 - 55
  • [48] EVALUATION AND MANAGEMENT OF THE TREATMENT-RESISTANT ANXIETY DISORDER PATIENT
    ROSENBAUM, JF
    [J]. BULLETIN OF THE MENNINGER CLINIC, 1992, 56 (02) : A50 - A60
  • [49] New therapies for treatment-resistant depression and anxiety - Introduction
    Nemeroff, CB
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2005, 66 : 3 - 4
  • [50] Recent advances in treatment-resistant generalized anxiety disorder
    Baldwin, David
    [J]. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2011, 15 : 5 - 5
12345